De Novo Variants in PTLC1 Gene Associated With Juvenile ALS
Using exome sequencing, researchers shared results of family-based genetic study on the genetic variants associated with juvenile amyotrophic lateral sclerosis.
Neuromuscular Diseases
Guidance for Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome During COVID-19
The International Myasthenia Gravis/COVID-19 Working Group has published a short guidance statement on the management of MG and Lambert-Eaton myasthenic syndrome during this novel pandemic.
OnabotulinumtoxinA Approved for Pediatric Lower Limb Spasticity
The FDA has approved Botox for the treatment of lower limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. The treatment was already approved for pediatric upper limb spasticity earlier this year.
MAPT H1 Haplotype Implicated in ALS Risk, With Genetic Overlap Between ALS and FTD
Investigators sought to identify genetic factors that may contribute to the risk for neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia.
Rituximab Improves Outcomes in Patients With Anti-MuSK Myasthenia Gravis
Patients with anti-muscle-specific kinase myasthenia gravis typically have a more severe disease presentation, with early bulbar, neck, and respiratory muscle weakness.
- Loading...
Loading...
Next post in Neuromuscular Disorders
Loading... 
Loading...